REG - Accrol Group Hldgs - Result of AGM

Accrol groupAnnouncement

24/10/2023 14:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231024:nRSX1460Ra&default-theme=true

RNS Number : 1460R  Accrol Group Holdings PLC  24 October 2023

24 October 2023

 

Accrol Group Holdings plc

("Accrol", the "Company" or the "Group")

AIM: ACRL

 

Result of 2023 Annual General Meeting

 

Accrol (AIM: ACRL), the UK's leading independent tissue converter, announces
that all of the resolutions set out in the Notice of AGM were passed by the
requisite majority at the Company's AGM, held earlier today.

 

Details of the proxy votes received by the Company are as follows:

 

 Resolution                                                                  For                  Against             Withheld
                                                                             No. of votes  %      No. of votes  %     No. of votes
 1. To receive the Annual Report and Accounts                                219,819,362   99.97  65,673        0.03  0
 2. To appoint BDO as Auditor and authorise the directors to fix their       219,781,647   99.96  90,747        0.04  12,641
 remuneration
 3. To approve the Directors' Remuneration Report                            212,665,237   96.72  7,207,157     3.28  12,641
 4. To re-elect Chris Welsh as a Director                                    219,334,006   99.75  548,180       0.25  2,849
 5. To authorise the Directors to allot relevant securities                  219,313,827   99.74  561,635       0.26  9,573
 6. To authorise the Directors to allot equity securities for cash without   214,032,998   97.34  5,842,464     2.66  9,573
 making a pre-emptive offer to shareholders*
 7. To authorise the Directors to make market purchases of ordinary shares*  214,174,005   97.4   5,710,716     2.6   314

 

 

*Special resolution

 

Notes:

 

 1.  Proxy appointments which gave discretion to the Chairman of the AGM have been
     included in

     "For" total for the appropriate resolution.
 2.  Votes "For" and "Against" any resolution are expressed as a percentage of
     votes validly cast for that resolution.
 3.  A "Vote withheld" is not a vote in law and is not counted in the calculation
     of the percentage of shares voted "For" or "Against".
 4.  The number of shares in issue on 17 October 2023 was 318,878,097 with no
     shares in treasury.
 5.  The full text of the resolutions passed at the AGM is available in the Notice
     of AGM on the Company's website:

     https://www.accrol.co.uk/investors/company-reports-presentations-and-circulars/
     (https://www.accrol.co.uk/investors/company-reports-presentations-and-circulars/)

 

 

 For further information, please contact:

 Accrol Group Holdings plc
 Dan Wright, Executive Chairman                 Via Belvedere Communications
 Gareth Jenkins, Chief Executive Officer
 Chris Welsh, Chief Financial Officer

 Zeus (Nominated Adviser & Broker)
 Dan Bate / Jordan Warburton                    Tel: +44 (0) 161 831 1512
 Dominic King                                   Tel: +44 (0) 203 829 5000

 Shore Capital Stockbrokers (Joint Broker)      Tel: +44 (0) 20 7408 4090
 Malachy McEntyre/ Mark Percy / James Thomas /
 Isobel Jones

 Belvedere Communications Limited
 Cat Valentine                                  Tel: +44 (0) 7715 769 078
 Keeley Clarke                                  Tel: +44 (0) 7967 816 525
                                                accrolpr@belvederepr.com
                                                (https://url.avanan.click/v2/___mailto:accrolpr@belvederepr.com___.YXAxZTpzaG9yZWNhcDphOm86M2MwYTQzNTFkNjBlNWI1NDY2ZDFlOGIzNGQ3MTQ2NTk6NjplZDQ5Ojk3ZmU0NGJlODE2ZDNiMDY2MTFjZmNmNjcyYWE3MDMwY2YzZWU3MGQxNjlkOGFkMzY3ZmE4NzA1ZGEyNWY4MmU6cDpU)

 

Overview of Accrol

 

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet
tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's
leading discounters and grocery retailers across the UK. The Group now
operates from five manufacturing sites which together supply c.21.5% (volume)
of the UK tissue market valued at c£2.5bn at retail sales value.

 

For more information, please visit www.accrol.co.uk
(https://url.avanan.click/v2/___http:/www.accrol.co.uk/___.YXAxZTpzaG9yZWNhcDphOm86M2MwYTQzNTFkNjBlNWI1NDY2ZDFlOGIzNGQ3MTQ2NTk6Njo0YzVkOmEwY2Q0OTZhMWE2YTM0NjE1YjlkMjAyNGQ1ZmI2M2FhNjlmZTFkZjE5Mzk5OTdiNjA3Zjk3MzBkMTBmOTU4ZWM6cDpU)
.

 

Link for Accrol Today video: https://www.accrol.co.uk/our-business/
(https://url.avanan.click/v2/___https:/www.accrol.co.uk/our-business/___.YXAxZTpzaG9yZWNhcDphOm86M2MwYTQzNTFkNjBlNWI1NDY2ZDFlOGIzNGQ3MTQ2NTk6NjoxZGMxOmJjYmM3OTRhZjZiZGRhOTUxZmJiZDU4YmUwYmMzYzgxOTBlZDlkMTVkMzkxMDIzMWI0NDNiMTEwZGExMTg1ZDg6cDpU)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGUSOOROVURUAA